Galeterone is a Copy Cat of Zytiga

Galeterone (TOK 001) is a new drug for prostate cancer that is undergoing clinical trials. This is one of a number of 17-heteroaryl substituted analogues of abiraterone (Zytiga). Galeterone has a 17-benzimidazole group in place of the 17-3-pyridyl group found in Abiraterone. Galeterone is therefore a copy cat version of Zytiga and should have the same clinical benefits.